A Prospective Trial of a Variable Compression System for Moderate to Severe Irritable Bowel Syndrome
NCT07540312
This study is recruiting at 3 US sites in 3 states, according to its ClinicalTrials.gov record last updated .
Summary
This prospective, interventional trial is intended to determine the safety and effectiveness of the Variable Compression System (VCS) device for Irritable Bowel Syndrome (IBS). This pilot study will enroll 20 subjects who will be required to wear the VCS device for a minimum of 6 hours a day and follow up at 21 days, 8 weeks, and 6 months post-device administration.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- IBS (Irritable Bowel Syndrome)
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- PGP Health
- Last updated on ClinicalTrials.gov
- April 29, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Florida · 1
- Central Florida Gastro Research · Kissimmee, FL
Illinois · 1
- UChicago Medicine AdventHealth Medical Group Gastroenterology at Bolingbrook · Bolingbrook, IL
Mississippi · 1
- Delta Gastroenterology PC · Southhaven, MS
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.